In our study plasma concentration of TGF-β1 did not differ significantly between AD and healthy dogs, whereas SMAD2 expression was downregulated in cAD patients, correlating with the decreased expression of VEGF detected in AD dogs. The gene discussed is VEGFA; the disease is Alzheimer disease.